• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Worldwide trends in asthma mortality.

作者信息

Sears M R

机构信息

Otago University Medical School, Dunedin, New Zealand.

出版信息

Bull Int Union Tuberc Lung Dis. 1991 Jun-Sep;66(2-3):79-83.

PMID:1684522
Abstract

Statistics for deaths from asthma yield widely variable mortality rates between countries. Validation studies show significant inaccuracies in certification of cause of death in older subjects, and probable underreporting of asthma deaths in some countries, explaining some of the international differences noted. The introduction of the ninth revision of the World Health Organisation International Classification of Diseases brought a step increase in reported asthma mortality rates in 1979, but the last decade has seen a gradual increase in mortality rates in many countries, especially in young people, not explained by this change in code. Diagnostic transfer does not adequately explain these increases. Individuals at risk of death from asthma are more likely to be non-caucasian, non-compliant, and young, with a history of previous life-threatening episodes, hospital admissions, and precipitous attacks. Studies of circumstances of death have emphasized overreliance on beta-agonists and underuse of corticosteroids as two primary deficiencies in management, but there remains debate about the causality of the association between increased asthma mortality and increased usage of beta-agonists. The gradual increase in asthma mortality seen in New Zealand over the last 40 years, with episodic increases in the rising baseline, together with similar but more gradual changes in other countries, raises concerns about whether current treatment practices may adversely affect asthma severity and mortality. Further studies are required to validate asthma mortality statistics, and to establish causation of deaths.

摘要

相似文献

1
Worldwide trends in asthma mortality.
Bull Int Union Tuberc Lung Dis. 1991 Jun-Sep;66(2-3):79-83.
2
Why are deaths from asthma increasing?哮喘致死人数为何在增加?
Eur J Respir Dis Suppl. 1986;147:175-81.
3
Trends in mortality from bronchial asthma in Switzerland, 1969-1993.1969 - 1993年瑞士支气管哮喘死亡率趋势
Rev Epidemiol Sante Publique. 1996 Apr;44(2):155-61.
4
Asthma mortality in New Zealand: a two year national study.新西兰的哮喘死亡率:一项为期两年的全国性研究。
N Z Med J. 1985 Apr 24;98(777):271-5.
5
Deaths with asthma in France, 2000-2005: a multiple-cause analysis.2000 - 2005年法国哮喘相关死亡情况:多病因分析
J Asthma. 2009 May;46(4):402-6. doi: 10.1080/02770900902795553.
6
Asthma mortality in the Danish child population: risk factors and causes of asthma death.丹麦儿童群体中的哮喘死亡率:哮喘死亡的风险因素及原因
Pediatr Pulmonol. 2003 Aug;36(2):142-7. doi: 10.1002/ppul.10305.
7
A multiple cause-of-death analysis of asthma mortality in the United States, 1990-2001.1990 - 2001年美国哮喘死亡率的多死因分析
J Asthma. 2005 Nov;42(9):757-63. doi: 10.1080/02770900500308189.
8
[Mortality related to asthma. Trends in France from 1970 to 1987].[与哮喘相关的死亡率。1970年至1987年法国的趋势]
Rev Mal Respir. 1992;9(5):495-501.
9
[Past and present asthma mortality: towards a shift in the secular trend?].[过去与现在的哮喘死亡率:世俗趋势会发生转变吗?]
Rev Epidemiol Sante Publique. 1993;41(5):363-73.
10
[Asthma-related mortality in the city of Rosário].[罗萨里奥市与哮喘相关的死亡率]
Medicina (B Aires). 1995;55(6):647-51.

引用本文的文献

1
Active-Ingredient Screening and Synergistic Action Mechanism of Shegan Mixture for Anti-Asthma Effects Based on Network Pharmacology in a Mouse Model of Asthma.基于网络药理学的哮喘小鼠模型中射干麻黄合剂抗哮喘作用的有效成分筛选及协同作用机制
Drug Des Devel Ther. 2021 Apr 29;15:1765-1777. doi: 10.2147/DDDT.S288829. eCollection 2021.
2
Asthma progression and mortality: the role of inhaled corticosteroids.哮喘进展和死亡率:吸入性皮质类固醇的作用。
Eur Respir J. 2019 Jul 18;54(1). doi: 10.1183/13993003.00491-2019. Print 2019 Jul.
3
Trends in asthma mortality in the 0- to 4-year and 5- to 34-year age groups in Brazil.
巴西0至4岁和5至34岁年龄组哮喘死亡率的趋势。
J Bras Pneumol. 2017 Jan-Feb;43(1):24-31. doi: 10.1590/S1806-37562015000000253.
4
Effect of different monotherapies on serum nitric oxide and pulmonary functions in children with mild persistent asthma.不同单药治疗对轻度持续性哮喘儿童血清一氧化氮和肺功能的影响。
Arch Med Sci. 2010 Dec;6(6):919-25. doi: 10.5114/aoms.2010.19302. Epub 2010 Dec 29.
5
Drug treatment of asthma in the 1990s: achievements and new strategies.20世纪90年代哮喘的药物治疗:成就与新策略。
Drugs. 1999 Jan;57(1):1-8. doi: 10.2165/00003495-199957010-00001.
6
Trends in asthma mortality among African Americans and whites in Chicago, 1968 through 1991.1968年至1991年芝加哥非裔美国人和白人哮喘死亡率的趋势。
Am J Public Health. 1994 Nov;84(11):1830-3. doi: 10.2105/ajph.84.11.1830.
7
The beta 2-agonist controversy. Observations, explanations and relationship to asthma epidemiology.β2激动剂的争议。观察、解释及其与哮喘流行病学的关系。
Drug Saf. 1994 Oct;11(4):259-83. doi: 10.2165/00002018-199411040-00005.
8
Measured bronchodilator use in preschool children with asthma.学龄前哮喘儿童支气管扩张剂的实际使用情况。
BMJ. 1995 May 6;310(6988):1161-4. doi: 10.1136/bmj.310.6988.1161.